source
- FDA issues final guidance on developing and labeling prescription drug appsThe FDA released its final guidance on Tuesday, outlining how drug sponsors should create, distribute, and label software applications that are used together with prescription medicines. The guida…
- Lawmakers push FDA to close loophole allowing import of counterfeit Eli Lilly obesity drugA bipartisan group of U.S. lawmakers is urging the Food and Drug Administration to address a regulatory gap that permits the importation of unapproved versions of retatrutide, an experimental obesi…